These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 10903487)
1. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma. Boulet LP; Cowie RL; Negro RD; Brett W; Gold M; Marques A; Thorburn WS; Stepner NM; Robson R Can Respir J; 2000; 7(3):239-47. PubMed ID: 10903487 [TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma. ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117 [TBL] [Abstract][Full Text] [Related]
3. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids. Chuchalin A; Jacques L; Frith L Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402 [TBL] [Abstract][Full Text] [Related]
4. New challenges for the Canadian Thoracic Society. Boulet LP Can Respir J; 2000 May; 7(3):217-218. PubMed ID: 10903485 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327 [TBL] [Abstract][Full Text] [Related]
7. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. FitzGerald JM; Boulet LP; Follows RM Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813 [TBL] [Abstract][Full Text] [Related]
8. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218 [TBL] [Abstract][Full Text] [Related]
9. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids. Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150 [TBL] [Abstract][Full Text] [Related]
10. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. Purucker ME; Rosebraugh CJ; Zhou F; Meyer RJ Chest; 2003 Oct; 124(4):1584-93. PubMed ID: 14555594 [TBL] [Abstract][Full Text] [Related]
11. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma. Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186 [TBL] [Abstract][Full Text] [Related]
13. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388 [TBL] [Abstract][Full Text] [Related]
14. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma. Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664 [TBL] [Abstract][Full Text] [Related]
15. Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial. Busse WW; Bateman ED; O'Byrne PM; Lötvall J; Woodcock A; Medley H; Forth R; Jacques L Allergy; 2014 Nov; 69(11):1522-30. PubMed ID: 25040613 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma. Medley H; Orozco S; Allen A Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247 [TBL] [Abstract][Full Text] [Related]
17. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129 [TBL] [Abstract][Full Text] [Related]
18. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily. Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361 [TBL] [Abstract][Full Text] [Related]
20. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]